Monte Rosa Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -25.77M-64.07M-108.50M-135.35M-72.73M
Depreciation and Depletion 0.54M2.13M3.75M6.22M8.12M
Share-based Compensation 0.35M5.20M11.66M16.67M18.13M
Gains from Sales and Divestitures 0.10M0.12M
Gains from Investment Securities -0.02M0.11M9.39M11.59M
Non-cash Items 4.74M11.42M
Cash from Operations -23.05M-59.36M-92.47M-43.80M42.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.54M2.13M3.75M6.22M8.12M
Change in Working Capital
Change in Receivables 0.19M-1.90M-0.33M
Change in Account Payables 3.44M-0.71M-0.74M5.76M6.25M
Change in Accured Expenses 1.13M6.59M1.03M3.56M4.18M
Other Working Capital Changes 1.38M0.70M2.13M50.00M83.38M
Investing Activities
Capital Expenditures 3.39M9.73M12.91M19.04M3.99M
Sales of Property, Plant and Equipment 0.08M0.11M0.06M
Change in Acquisitions & Divestments 45.63M
Cash from Investing Activities -3.39M-9.65M-219.22M88.80M-44.45M
Financing Activities
Other financing activities 0.44M0.23M0.34M0.58M0.53M
Cash from Financing Activities 60.06M377.56M20.47M27.49M98.89M
Additional items
Change in Cash 33.62M308.55M-291.22M72.49M96.44M
Free Cash Flow -26.44M-69.09M-105.38M-62.84M38.01M
Net Cash Flow 33.62M308.55M-291.22M72.49M96.44M